The molecular clocks at chromosome ends
Telomeres are nucleoprotein structures at the ends of linear chromosomes, composed of tandem repeats of the hexanucleotide sequence TTAGGG in vertebrates. Human telomeres span approximately 5,000 to 15,000 base pairs and terminate in a single-stranded 3' overhang of 150-200 nucleotides. This overhang folds back to form a T-loop, hiding the chromosome end from the DNA damage response machinery.
The shelterin complex -- a six-protein assembly comprising TRF1, TRF2, POT1, TIN2, TPP1, and RAP1 -- binds telomeric DNA and prevents it from being recognized as a double-strand break. Without shelterin, exposed chromosome ends trigger ATM and ATR kinase pathways, leading to inappropriate DNA repair: non-homologous end joining fuses chromosomes together, creating dicentric chromosomes that shatter during cell division.
Conventional DNA polymerases cannot fully replicate the 3' end of linear DNA -- the "end replication problem" identified by James Watson and Alexei Olovnikov in the early 1970s. With each cell division, telomeres shorten by 50 to 200 base pairs. When telomere length falls below a critical threshold, cells enter replicative senescence (the Hayflick limit) or apoptosis. Telomerase, discovered by Carol Greider and Elizabeth Blackburn in 1985, can extend telomeres but is silenced in most adult somatic cells.
Inherited mutations in telomerase components cause telomere biology disorders: dyskeratosis congenita, idiopathic pulmonary fibrosis, and aplastic anemia. Paradoxically, telomere maintenance is also critical to cancer: approximately 85% of human cancers reactivate telomerase to achieve replicative immortality, while the remaining 15% use the Alternative Lengthening of Telomeres (ALT) pathway based on homologous recombination.
Current research explores telomerase inhibition as anti-cancer therapy, the role of telomere dysfunction in age-related diseases, and the complex signaling between telomeres and mitochondria. Single-cell telomere length measurement technologies are enabling population-level studies that may reveal how telomere dynamics influence healthspan. The 2009 Nobel Prize in Physiology or Medicine, awarded to Blackburn, Greider, and Szostak, recognized the fundamental importance of telomere biology.